NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY

    公开(公告)号:EP4421181A2

    公开(公告)日:2024-08-28

    申请号:EP24162808.0

    申请日:2015-09-18

    申请人: Genomatica, Inc.

    IPC分类号: C12P7/16

    摘要: The invention provides non-natural microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA, or oxaloacetate and acetyl-CoA. Embodiments of the invention include microbial organisms having a pathway to acetyl-CoA and oxaloacetate that includes phosphoketolase (a PK pathway). The organisms also have either (i) a genetic modification that enhances the activity of the non-phosphotransferase system (non-PTS) for sugar uptake, and/or (ii) a genetic modification(s) to the organism's electron transport chain (ETC) that enhances efficiency of ATP production, that enhances availability of reducing equivalents or both. The microbial organisms can optionally include (iii) a genetic modification that maintains, attenuates, or eliminates the activity of a phosphotransferase system (PTS) for sugar uptake. The enhanced carbon flux through acetyl-CoA and oxaloacetate can be used for production of a bioderived compound, and the microbial organisms can further include a pathway capable of producing the bioderived compound.

    MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF HEXAMETHYLENEDIAMINE

    公开(公告)号:EP4273255A3

    公开(公告)日:2024-01-03

    申请号:EP23182826.0

    申请日:2010-05-07

    申请人: Genomatica, Inc.

    摘要: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.

    METHODS AND ORGANISMS FOR THE GROWTH-COUPLED PRODUCTION OF 1,4-BUTANEDIOL

    公开(公告)号:EP2679676B1

    公开(公告)日:2018-07-18

    申请号:EP13001197.6

    申请日:2008-08-06

    申请人: Genomatica, Inc.

    IPC分类号: C12N9/04 C12P7/18

    CPC分类号: C12P7/18 B01D3/002 C12N9/0006

    摘要: The invention provides a non-naturally occurring microorganism comprising one or more gene disruptions, the one or more gene disruptions occurring in genes encoding an enzyme obligatory to coupling 1,4-butanediol production to growth of the microorganism when the gene disruption reduces an activity of the enzyme, whereby theone or more gene disruptions confers stable growth-coupled production of 1,4-butanediol onto the non-naturally occurring microorganism. The microorganism can further comprise a gene encoding an enzyme in a 1,4-butanediol (BDO) biosynthetic pathway. The invention additionally relates to methods of using microorganisms to produce BDO.

    ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL
    8.
    发明公开
    ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL 审中-公开
    ORGANISMEN ZUR HERSTELLUNG VON 1,3-BUTANDIOL

    公开(公告)号:EP3135760A1

    公开(公告)日:2017-03-01

    申请号:EP16168278.6

    申请日:2010-04-30

    申请人: Genomatica, Inc.

    IPC分类号: C12N1/21 C12P7/18 C12N9/04

    摘要: A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2- one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl- CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.

    摘要翻译: 非天然存在的微生物体包括具有1,3-丁二醇(1,3-BDO)途径的微生物生物,其具有至少一种编码1,3-BDO途径酶的外源核酸,其表达量足以产生1 ,3-BDO。 途径包括选自2-氨基-4-酮戊酸酯(AKP)硫解酶,AKP脱氢酶,2-氨基-4-羟基戊酸转氨酶,2-氨基-4-羟基戊酸酯氧化还原酶(脱氨基),2- 4-羟基戊酸脱羧酶,3-羟基丁醛还原酶,AKP氨基转移酶,AKP氧化还原酶(脱氨基),2,4-二氧代戊酸脱羧酶,3-氧代丁醛还原酶(还原酮),3-氧代丁醛还原酶 ),4-羟基-2-丁酮还原酶,AKP脱羧酶,4-氨基丁-2-酮氨基转移酶,4-氨基丁-2-酮氧化还原酶(脱氨基),4-氨基丁-2-酮氨裂解酶 乙酰乙酰辅酶A还原酶(CoA依赖性醛形成),乙酰乙酰辅酶A还原酶(CoA依赖性醇成型),乙酰乙酰辅酶A还原酶(酮 还原),3-羟基丁酰辅酶A还原酶(醛形成),3-羟基丁酸 yyl-CoA还原酶(醇形成),4-羟基丁酰辅酶A脱水酶和巴豆酸酶。 一种生产1,3-BDO的方法包括在条件和足够的时间内培养这些微生物生产1,3-BDO。

    MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF HEXAMETHYLENEDIAMINE

    公开(公告)号:EP4273255A2

    公开(公告)日:2023-11-08

    申请号:EP23182826.0

    申请日:2010-05-07

    申请人: Genomatica, Inc.

    IPC分类号: C12P13/00

    摘要: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.